Biomedical

Novartis Pharmaceuticals Corporation researches, develops manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, respiratory, dermatology and infectious disease areas.

Ipsen is a global biotechnology specialty care company. Its strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology, and primary care drugs, significantly contributing to research financing.

ESA enables answers to pressing applications challenges by
applying its expertise in specialty detection and electrochemistry, combined with components, kits, and reagents, for analytical laboratories, commercial diagnostics laboratories, and the clinical point-of-care setting.

We are recognized for continuing invention and innovation in computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, digital radiography (DR), patient monitoring, and aviation security, with growing capabilities in molecular imaging and advanced motion controls.

Pulmatrix is developing new breakthrough therapies with the vision of fundamentally changing the way we treat, prevent and control infectious and progressive respiratory diseases.

Precision Optics Corporation has provided state of the art optics and optical systems for medical, biomedical, and industrial applications. As diagnostic and surgical techniques advanced to smaller and less invasive tools and equipment, Precision Optics responded with micro precision™ optical components, assemblies, and products

Entegris serves high technology markets by purifying, protecting and transporting critical materials used in manufacturing processes. These critical materials are often the very building blocks in producing many of the world's leading microelectronic products. Customers throughout the semiconductor, data storage and fuel cell industries rely upon Entegris to precisely control microcontamination and reliably handle substrates.

GVD Corporation is a surface technology company that produces engineered polymer coatings that are unattainable using conventional technologies. GVD’s technology is uniquely suited to meet the growing demands for super-thin coatings for medical devices, membranes, textiles, and consumer goods as well as a wide range of other applications, both every day and cutting edge.